医学
肺外结核
肺结核
内科学
观察研究
流行病学
中国
比例(比率)
病理
结核分枝杆菌
地理
地图学
考古
作者
Wanli Kang,Shengsheng Liu,Jian Du,Peijun Tang,Hongyan Chen,Jianxiong Liu,Jinshan Ma,Mingwu Li,Jingmin Qin,Wei Shu,Peilan Zong,Yi Zhang,Yongkang Dong,Zhiyi Yang,Zaoxian Mei,Qunyi Deng,Pu Wang,Wenge Han,Xiaofeng Yan,Ling Chen
标识
DOI:10.1016/j.ijid.2021.11.019
摘要
AimsA high proportion of all patients with tuberculosis (TB) present with extrapulmonary TB (EPTB), including concurrent EPTB involving more than one extrapulmonary lesion site. However, previous reports only characterized lesions of single-site EPTB cases. This study aimed to investigate epidemiological characteristics and association rules of concurrent EPTB cases in China.MethodsAn observational multi-centre study of 208,214 patients with EPTB lesions was undertaken in China from January 2011 to December 2017. Multi-variable logistic regression analysis was used to identify associations between gender and concurrent EPTB, and age and concurrent EPTB. Association rules were analysed for significance using the Apriori algorithm.ResultsThe most common EPTB lesion was tuberculous pleurisy (49.8%), followed by bronchial TB (14.8%) and tuberculous meningitis (7.6%). The most common type of concurrent EPTB was tuberculous pleurisy concurrent with tuberculous peritonitis (1.80%). In total, 22 association rules, including 20 strong association rules, were identified; among these, the highest confidence rates were found for tuberculous myelitis concurrent with tuberculous meningitis, and sacral TB concurrent with lumbar vertebral TB. The association rules of EPTB concurrent with other EPTB types were found to vary with gender and age. The confidence rate of tuberculous myelitis concurrent with tuberculous meningitis was higher in females (83.67%) than males, and was highest in patients aged 25–34 years (87.50%).ConclusionsMany types of concurrent EPTB were found. Greater awareness of concurrent EPTB disease characteristics is needed to ensure timely clinical diagnosis and treatment of this disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI